INSURANCE: Allstate wants to hike auto rates again. Will regulators allow it? PAGE 3
JOE CAHILL: Boeing should broaden its talent pool. PAGE 4
CHICAGOBUSINESS.COM | September 13, 2021 | $3.50
Why ivermectin is a lose-lose for hospitals With COVID patients taking pleas for the dewormer to court, hospitals are forced to make a no-win choice
NEWSCOM
BY STEPHANIE GOLDBERG
Architect Helmut Jahn stands in front of a photo of O’Hare International Airport’s Terminal 1 in 2012.
What’s the future of Jahn without Helmut? It’s the sort of metamorphosis other ‘starchitect’ firms have managed after the death of a marquee name, but this one faces special challenges. BY ALBY GALLUN
in business. But it could be especially IN AUGUST 2017, Helmut Jahn’s protetough for Jahn, which now lacks a charge and successor, Francisco Gonzalez ismatic, high-profile designer to carry Pulido, walked out the door, leaving to on Helmut Jahn’s legacy. start his own architecture firm. His deThe late architect groomed Gonzaparture, barely noticed then, carries lez Pulido for that role, elevating him greater significance today, nearly five to president of the firm in 2012. But the months after Jahn’s tragic death. two couldn’t reach an agreement on the Jahn’s Chicago architecture practice, simply named Jahn, faces an uncertain Francisco Gonzalez Pulido transition, and they broke up in 2017— amicably, according to Gonzalez Pulido, future following the loss of its 81-yearold leader to a bike accident in May. It’s a difficult now principal of Chicago-based FGP Atelier. transition for any firm that relies heavily on one person’s creative genius and star power to bring See JAHN on Page 22
Increasing pressure from COVID-19 patients and their families seeking unapproved treatments puts hospitals in a legal quandary. Ivermectin has long been used to kill parasites in animals and humans. But despite being touted as a coronavirus cure by conservative media personalities, the anti-parasitic hasn’t proven to be safe or effective for COVID patients. Even so, some are demanding that hospitals administer the controversial drug—and they’re
taking their demands to court. Hospitals could be forced to choose between defying a court order and administering an inappropriate medication, potentially exposing themselves to liability if patients have adverse reactions. Some organizations will be compelled to find workarounds, like west suburban Elmhurst Hospital, which granted an unaffiliated physician emergency privileges to administer ivermectin on its premises. But no decision is without risk. See IVERMECTIN on Page 14
New report details self-dealing at TRS
Inspector general finds teachers pension brass stood by as a former executive steered work to his company BY A.D. QUIG A state investigative report on the Illinois Teachers’ Retirement System reveals conflicts of interest involving a former high-ranking official of the state’s largest employee pension plan, which has seen a string of senior executives depart in the past 16 months. The report released Aug. 19 by the Office of the Executive Inspector General found that Jay Singh maintained ties to a TRS subcontractor while he served as chief information officer of the fund.
The continuing relationship with Singh3, a consulting firm that collected nearly $900,000 for its work on a TRS technology project, violated Jay Singh the fund’s conflict of interest policy, according to the report. The OEIG also found that TRS executives took no steps to verify Singh’s assertion that he See TRS on Page 18
NEWSPAPER l VOL. 44, NO. 37 l COPYRIGHT 2021 CRAIN COMMUNICATIONS INC. l ALL RIGHTS RESERVED
P001_CCB_20210913.indd 1
CRAIN’S LIST
REAL ESTATE
Get the rundown on the Chicago area’s biggest law firms. PAGE 12
Look inside a late-career Wright on a Lake Michigan bluff. PAGE 23
9/10/21 4:08 PM